The Battle for Germany’s Medical Cannabis Market: Who’s Fighting for What
Today, (Wednesday, January 14), a public hearing will bring together 22 hand-picked experts for a debate on the future country’s near-billion-euro medical cannabis industry.
Today, (Wednesday, January 14), a public hearing will bring together 22 hand-picked experts for a debate on the future country’s near-billion-euro medical cannabis industry.
Germany’s cannabis decriminalisation bill is set to endure its final and potentially most dangerous political test this week, with government sources suggesting its future now hangs in the balance.
Germany’s landmark CanG bill, which is scheduled to legalise the consumption and possession of cannabis from April 01, is looking increasingly likely to be delayed until at least October.
Germany’s landmark Cannabis Act (CanG), which would establish an adult-use cannabis framework in the European Union’s most populous country, has been pushed back by a number of months.
On Friday (September 29), opponents of Germany’s Cannabis Act (CanG) failed to prevent the bill from progressing in the German Federal Council (Bundesrat).
TWO senior figures in the European cannabis industry are leading the fight against over-zealous German law enforcement in a move which resonates with the recent KanaVape case.